Neurocrine Biosciences (NBIX) Enterprise Value

Price: $95.65
Market Cap: $9.54B
Avg Volume: 1.35M
Country: US
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Beta: 0.334
52W Range: $93.59-157.98
Website: Neurocrine Biosciences
Enterprise Value Summary (Quarterly)

According to Neurocrine Biosciences's latest quarterly financial reports:

  • The enterprise value (EV) is 13.93B, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
  • The market capitalization is 13.70B, which is calculated by multiplying the current share price by the total number of outstanding shares.
  • The stock price is $136.5, with 100.40M shares outstanding.
  • The company has 233.00M in cash and cash equivalents and 455.10M in total debt.

Enterprise Value (EV) Formula:

EV = Market Cap + Total Debt - Cash and Cash Equivalents

Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.

Enterprise Value

$13.93B

Market Cap

$13.70B

Total Debt

$455.10M

Cash and Equivalents

$233.00M

Historical Enterprise Value
$16.00B$16.00B$12.00B$12.00B$8.00B$8.00B$4.00B$4.00B$0.00$0.00Enterprise Value20062006200720072008200820092009201020102011201120122012201320132014201420152015201620162017201720182018201920192020202020212021202220222023202320242024
Neurocrine Biosciences Historical Enterprise Values

The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.

Date Enterprise Value EV Change (%) Stock Price Number of Shares Market Cap Cash & Equivalents Total Debt
December 31, 2024 $13.93B 20.57% $136.5 100.40M $13.70B $233.00M $455.10M
September 30, 2024 $11.55B -19.08% $115.22 101.10M $11.65B $349.10M $251.40M
June 30, 2024 $14.27B 0.10% $140.11 100.80M $14.12B $139.70M $291.60M
March 31, 2024 $14.26B 8.51% $141.38 99.80M $14.11B $396.30M $546.90M
December 31, 2023 $13.14B 19.74% $131.76 98.40M $12.97B $251.10M $428.40M
September 30, 2023 $10.98B 17.99% $112.5 97.90M $11.01B $293.70M $255.80M
June 30, 2023 $9.30B -8.61% $94.3 97.60M $9.20B $160.20M $258.80M
March 31, 2023 $10.18B -11.50% $101.22 97.10M $9.83B $-90.40M $259.90M
December 31, 2022 $11.50B 12.45% $119.44 96.30M $11.50B $262.90M $262.90M
September 30, 2022 $10.23B 8.53% $106.21 95.80M $10.17B $212.20M $265.80M
June 30, 2022 $9.42B 3.06% $97.48 95.60M $9.32B $163.30M $268.60M
March 31, 2022 $9.14B 11.76% $93.75 95.30M $8.93B $270.20M $480.20M
December 31, 2021 $8.18B -11.15% $85.17 94.90M $8.08B $340.80M $440.40M
September 30, 2021 $9.21B -0.70% $95.91 94.70M $9.08B $311.10M $437.10M
June 30, 2021 $9.27B 0.39% $97.32 94.60M $9.21B $368.00M $435.30M
March 31, 2021 $9.24B 7.75% $97.25 94.20M $9.16B $352.60M $429.50M
December 31, 2020 $8.57B 0.90% $95.85 93.50M $8.96B $801.00M $412.30M
September 30, 2020 $8.50B -25.69% $96.16 92.90M $8.93B $944.70M $508.00M
June 30, 2020 $11.43B 37.32% $122 93.00M $11.35B $415.10M $503.80M
March 31, 2020 $8.33B -19.10% $86.55 92.60M $8.01B $187.00M $499.70M
December 31, 2019 $10.29B 19.80% $107.49 92.20M $9.91B $112.28M $495.50M
September 30, 2019 $8.59B 5.94% $90.11 91.90M $8.28B $166.64M $478.07M
June 30, 2019 $8.11B -4.21% $85.2 91.40M $7.79B $140.99M $464.65M
March 31, 2019 $8.47B 25.88% $88.69 91.10M $8.08B $72.78M $460.58M
December 31, 2018 $6.73B -41.25% $71.41 90.74M $6.48B $141.71M $388.50M
September 30, 2018 $11.45B 26.32% $124.36 90.56M $11.26B $195.73M $383.65M
June 30, 2018 $9.06B 18.90% $98.24 90.10M $8.85B $166.42M $378.88M
March 31, 2018 $7.62B 8.99% $82.93 89.53M $7.42B $175.31M $374.21M
December 31, 2017 $6.99B 30.95% $77.59 88.67M $6.88B $254.71M $369.62M
September 30, 2017 $5.34B 30.21% $61.28 85.58M $5.24B $267.82M $365.11M
June 30, 2017 $4.10B 10.41% $46 88.06M $4.05B $309.50M $360.68M
March 31, 2017 $3.72B 13.97% $43.3 87.28M $3.78B $64.09M $-
December 31, 2016 $3.26B -24.10% $38.7 86.39M $3.34B $83.27M $-
September 30, 2016 $4.29B 11.44% $50.64 86.78M $4.39B $99.76M $-
June 30, 2016 $3.85B 16.59% $45.45 86.69M $3.94B $86.25M $-
March 31, 2016 $3.31B -31.15% $39.55 86.50M $3.42B $115.30M $-
December 31, 2015 $4.80B 43.33% $56.57 86.18M $4.88B $74.19M $-
September 30, 2015 $3.35B -15.24% $39.79 85.86M $3.42B $66.38M $-
June 30, 2015 $3.95B 30.85% $47.76 85.52M $4.08B $132.07M $-
March 31, 2015 $3.02B 80.87% $39.71 80.35M $3.19B $170.26M $-
December 31, 2014 $1.67B 43.83% $22.34 76.14M $1.70B $31.01M $-
September 30, 2014 $1.16B 6.69% $15.67 75.95M $1.19B $29.05M $-
June 30, 2014 $1.09B 6.10% $14.835 75.88M $1.13B $37.45M $-
March 31, 2014 $1.03B 77.91% $16.1 70.26M $1.13B $105.53M $-
December 31, 2013 $576.50M -20.57% $9.34 66.52M $621.28M $44.79M $-
September 30, 2013 $725.80M -15.81% $11.32 67.20M $760.69M $34.89M $-
June 30, 2013 $862.15M 14.29% $13.57 66.80M $906.46M $44.31M $-
March 31, 2013 $754.33M 74.22% $11.8 66.60M $785.88M $31.55M $-
December 31, 2012 $432.96M -11.68% $7.48 66.41M $496.72M $63.75M $-
September 30, 2012 $490.23M 1.81% $8.06 66.34M $534.72M $44.49M $-
June 30, 2012 $481.49M 12.39% $7.895 66.31M $523.51M $42.02M $-
March 31, 2012 $428.43M -12.36% $7.97 63.41M $505.37M $76.94M $-
December 31, 2011 $488.87M 68.07% $8.5 63.41M $538.98M $50.11M $-
September 30, 2011 $290.87M -31.66% $5.98 55.25M $330.38M $39.52M $-
June 30, 2011 $425.59M 8.31% $8.05 55.21M $444.43M $18.84M $-
March 31, 2011 $392.93M 7.56% $7.59 54.98M $417.32M $24.39M $-
December 31, 2010 $365.31M 38.61% $7.64 54.89M $419.36M $54.05M $-
September 30, 2010 $263.56M 18.99% $6.06 54.84M $332.35M $77.33M $8.53M
June 30, 2010 $221.50M 186.98% $5.6 54.84M $307.08M $95.12M $9.54M
March 31, 2010 $77.18M -23.58% $2.55 46.62M $118.88M $52.22M $10.53M
December 31, 2009 $101.00M -0.20% $2.72 46.62M $126.80M $37.33M $11.53M
September 30, 2009 $101.20M -4.23% $3.05 39.10M $119.24M $35.32M $17.28M
June 30, 2009 $105.67M 1.77% $3.23 39.05M $126.12M $38.62M $18.16M
March 31, 2009 $103.83M 88.61% $3.55 38.67M $137.27M $51.66M $18.22M
December 31, 2008 $55.05M -45.20% $3.2 38.60M $123.52M $68.47M $-
September 30, 2008 $100.46M 44.20% $4.69 38.45M $180.31M $80.12M $276.00K
June 30, 2008 $69.67M -30.59% $4.19 38.42M $160.98M $91.92M $601.00K
March 31, 2008 $100.37M 33.64% $5.4 38.33M $206.98M $107.64M $1.02M
December 31, 2007 $75.10M -80.04% $4.54 38.17M $173.28M $99.66M $1.49M
September 30, 2007 $376.26M -11.70% $9.91 37.99M $376.48M $50.35M $50.13M
June 30, 2007 $426.11M -4.84% $11.23 37.97M $426.39M $51.48M $51.20M
March 31, 2007 $447.80M 21.84% $12.5 37.91M $473.85M $78.46M $52.40M
December 31, 2006 $367.54M -4.86% $10.42 37.90M $394.88M $80.98M $53.64M
September 30, 2006 $386.31M 4.25% $10.75 37.87M $407.08M $75.76M $54.99M
June 30, 2006 $370.58M -84.35% $10.6 37.76M $400.30M $86.17M $56.45M
March 31, 2006 $2.37B 1.59% $64.54 37.35M $2.41B $101.49M $57.95M
December 31, 2005 $2.33B 30.09% $62.73 37.00M $2.32B $49.95M $59.40M
September 30, 2005 $1.79B 15.15% $49.19 36.71M $1.81B $75.38M $60.99M
June 30, 2005 $1.56B 10.10% $42.06 36.65M $1.54B $48.50M $62.63M
March 31, 2005 $1.41B - $38.06 36.60M $1.39B $44.57M $64.41M

Related Metrics

Explore detailed financial metrics and analysis for NBIX.